©The Author(s) 2025.
World J Gastrointest Oncol. Aug 15, 2025; 17(8): 105818
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.105818
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.105818
Table 2 Summary of tumor perfusion patterns in patients
| Perfusion type | Before treatment | 1 month after treatment | 3 months after treatment | 6 months after treatment | F value | P value |
| Enhanced (normal perfusion) | 68.25 ± 6.23 | 62.75 ± 5.99 | 58.50 ± 5.13 | 53.75 ± 5.28 | 4.378 | 0.03 |
| Uniform (low perfusion) | 21.50 ± 4.56 | 26.50 ± 4.72 | 28.00 ± 4.50 | 31.25 ± 4.89 | 5.187 | 0.022 |
| Non-uniform (low perfusion) | 10.25 ± 3.79 | 10.75 ± 4.12 | 13.50 ± 4.12 | 15.00 ± 3.89 | 6.123 | 0.016 |
| Total perfusion rate | 68.25 ± 6.23 | 62.75 ± 5.99 | 58.50 ± 5.13 | 53.75 ± 5.28 | 4.378 | 0.03 |
- Citation: Chen LP, Dong Y, He JG, Yang QQ, Hu ZW. Contrast-enhanced ultrasound in evaluating the curative effect of interventional therapy in patients with liver cancer. World J Gastrointest Oncol 2025; 17(8): 105818
- URL: https://www.wjgnet.com/1948-5204/full/v17/i8/105818.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i8.105818